Study on the potential molecular mechanism of Ziyabiti tablets on type 2 diabetes based on network pharmacology
10.12173/j.issn.1008-049X.202310060
- VernacularTitle:基于网络药理学研究孜亚比提片对2型糖尿病的潜在分子机制
- Author:
Simayi MAIMAITI
1
;
Aierken AIZEZIJIANG
;
Yan HU
;
Aihaiti WUSIMAN
Author Information
1. 新疆医科大学第一附属医院药学部(乌鲁木齐 830011)
- Keywords:
Ziyabiti tablets;
Type 2 diabetes;
Network pharmacology;
Molecular mechanism;
Quercetin;
Kaempferol
- From:
China Pharmacist
2024;27(2):192-198
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the molecular mechanism of Ziyabiti tablets in the treatment of type 2 diabetes(T2DM)by network pharmacology.Methods The chemical components and related targets of Ziyabiti tablets were obtained from TCMSP,ETCM and CNKI,and the targets of T2DM were screened by OMIM and GeneCards databases.The"drug-component-target"network was built by Cytoscape 3.6.1 to screen out the core components and the core targets were screened by protein-protein interaction network.GO functional analysis and KEGG pathway enrichment analysis were performed by DAVID database.Results A total of 144 active components of Ziyabiti tablets were collected in this study,and quercetin,kaempferol,isorhamnetin and so on with higher degree values.There were 823 related targets,of which 700 were related to T2DM,including SRC,MAPK1,MAPK3,etc.GO function analysis suggested that it was related to molecular functions such as signal transduction,protein phosphorylation and protein binding.The main signaling pathways involved in KEGG pathway enrichment analysis were AGE-RAGE signaling pathways in lipid and atherosclerosis,prostate cancer,and diabetic complications.Conclusion Ziyabiti tablets have the characteristics of multi-component,multi-target,and multi-pathway synergistic intervention in the treatment of T2DM,which is mainly composed of quercetin,kaempferol,isorhamnetin and other components to regulate AGE-RAGE signaling pathways through SRC,MAPK1,MAPK3 targets.
